Bleeding Disorders

• FDA approval · 2021-02-12
  FDA Approved: AMINOCAPROIC ACID — Original Application (Biocon Pharma Inc.)

  FDA approved Biocon Pharma Inc.'s aminocaproic acid from an original application (ANDA213928), making it an approved generic therapy to trea…

• FDA approval · 2021-01-26
  FDA Approved: AMINOCAPROIC ACID — Original Application (Biocon Pharma Inc.)

  FDA approves Biocon Pharma Inc.'s aminocaproic acid as an original ANDA, authorizing its marketing as an antifibrinolytic to help control or…

• FDA approval · 2019-08-23
  FDA Approved: AMINOCAPROIC ACID — Original Application (Amneal Pharmaceuticals NY LLC)

  FDA approved a generic aminocaproic acid product from Amneal Pharmaceuticals NY LLC under an Original Application (ANDA 212780). This repres…

• FDA approval · 2018-11-27
  FDA Approved: AMINOCAPROIC ACID — Original Application (Vitruvias Therapeutics)

  FDA approved Vitruvias Therapeutics' original application for aminocaproic acid, a generic antifibrinolytic. The approval covers its use to …

• FDA approval · 2012-12-27
  FDA Approved: TRANEXAMIC ACID — Original Application (Actavis Pharma, Inc.)

  FDA approved a generic tranexamic acid product from Actavis Pharma, Inc. under an Original Application; tranexamic acid is used to prevent o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.